Skip to main content
Clinical Trials/NCT05498714
NCT05498714
Unknown
Not Applicable

Improved Bowel Cleansing Method for Colonoscopy Based on High Risk Population of Bowel Preparation#a Single-center,Endoscopist-blinded Randomized Controlled Trial

Renmin Hospital of Wuhan University1 site in 1 country150 target enrollmentJuly 18, 2022

Overview

Phase
Not Applicable
Intervention
PEG+lactulose
Conditions
Bowel Preparation Before Colonoscopy
Sponsor
Renmin Hospital of Wuhan University
Enrollment
150
Locations
1
Primary Endpoint
Boston Bowel Preparation Scale
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to observe the difference in bowel preparation quality between compound sodium picosulfate#CSP combined with lactulose and polyethylene glycol electrolyte#PEG combined with lactulose in high-risk population.

Detailed Description

The quality of bowel preparation is crucial for colonoscopy. Some high-risk factors for inadequate bowel preparation have been identified , including age \>70, previous colon surgery, constipation, diabetes, Parkinson's disease, history of stroke or spinal cord injury, prior history of inadequate bowel preparation, body mass index (BMI) \>25, use of tricyclic antidepressant or narcotics. Patients were considered as high risk if they have any of the above factors.This is a single-center ,endoscopist-blinded study to compare the efficacy of CSP combined with lactulose and PEG combined with lactulose in bowel preparation. In colonoscopy procedures, endoscopists who were blinded to the intervention evaluated the overall quality of colonoscopy cleaning according to the Boston Bowel Preparation Scale. Patients' tolerance, defecation, adverse events and adenoma detection rate (ADR) were also evaluated.

Registry
clinicaltrials.gov
Start Date
July 18, 2022
End Date
June 30, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

ChenMingkai

Professor

Renmin Hospital of Wuhan University

Eligibility Criteria

Inclusion Criteria

  • Adults undergoing colonoscopy who have at least one risk factor: age\>70, previous colon surgery, constipation, diabetes, Parkinson's disease, history of stroke or spinal cord injury, prior history of inadequate bowel preparation, body mass index (BMI) \>25, use of tricyclic antidepressant or narcotics.

Exclusion Criteria

  • presence of any contraindications for colonoscopy (gastrointestinal obstruction or perforation,severe acute inflammatory bowel disease,toxic megacolon,severe heart failure,unable to swallow,severe heart failure,etc);
  • Patients with galactosemia;
  • hypersensitivity to any of the ingredients;
  • Pregnancy or lactation;
  • Use of lactulose,prokinetic agents or purgatives within 7 days;
  • Unwilling to sign informed consent.

Arms & Interventions

the control group

The dosing regimen of high-risk patients will be PEG combined with lactulose.

Intervention: PEG+lactulose

CSP+lactulose group

The dosing regimen of high-risk patients will be CSP combined with lactulose.

Intervention: CSP+lactulose

Outcomes

Primary Outcomes

Boston Bowel Preparation Scale

Time Frame: during colonoscopy

Cleanliness of the colon during colonoscopy will be evaluated by the Boston Bowel Preparation Scale which is a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side. The total BBPS score ranged from 0 to 9. If total BostonBowel Preparation Score ≥6 with each segmental BBPS≥2, we regard it as adequate bowel preparation.

Secondary Outcomes

  • Adenoma Detection Rate(2 days)
  • Rate of adverse events(2 days)
  • Cecal intubation rate(during colonoscopy)
  • Polyp Detection Rate(2 days)
  • defecation frequency(2 days)
  • Cecal intubation time(during colonoscopy)
  • Withdrawal time(during colonoscopy)
  • patient satisfaction Assessment(2 days)

Study Sites (1)

Loading locations...

Similar Trials